Mean platelet volume as a Low-Cost discriminatory marker for thrombotic risk assessment in Yemeni type 2 diabetic patients: A proposal for Resource-Limited settings

MPV ≥ 11.5 fL shows promise as a highly discriminatory, low-cost marker of thrombotic risk in Yemeni T2DM patients. We propose that routine MPV testing should be considered for integration into national diabetic guidelines in Yemen and similar conflict-affected settings. This evidence-based, low-cost strategy could contribute to improved preventive care and reduce the burden of thrombosis where resources are most scarce.